Abstract
In vitro exposure of malignant prostate cell lines to ascorbic acid-menadione showed that tumor cells were killed through a mechanism named autoschizis. Experimental animal studies showed that autoschizis is also evident when ascorbic acid-menadione is administered to nude mice with implanted human prostate tumors. Prostate-specific antigen (PSA) is a known serum marker of prostate tumor cells specific activity. Recently, total serum homocysteine has been identified as a marker of tumor cell numbers with sensitivity for early detection of tumor cell death induced by treatments. A clinical trial with prostate cancer patients submitted to the association of ascorbic acid-menadione was performed and PSA/homocysteine was assessed in the follow-up. The early response in serum PSA and homocysteine levels was reported. The results showed that ascorbic acid-menadione produced an immediate drop in tumor cell numbers as assessed by homocysteine levels. Serum PSA levels showed an early rise and later dropped. These results suggest that autoschizis can also be induced by this pharmacological association at the clinical level in prostate cancer patients. Further studies are being performed in order to research if these results can be found with other primary tumors as it was shown in in vitro and experimental models. Ascorbic acid-menadione could be emerging as a new anti-tumoral chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Riordan, N.H., et al. (1995). Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med. Hypotheses 44:207–213.
Moertel, C.G., et al. (1985). High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N. Engl. J. Med. 312(3):137–141.
Chlebowski, R.T., et al. (1985). Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation. Cancer Treat. Rep. 69(5):527–532.
Gabai, V.L., et al. (1990). Oxidative stress, disturbance of energy balance, and death of ascites tumor cells under menadione (vitamin K3) action. Biomed. Sci. 1(4):407–413.
Bellomo, G., et al. (1990). Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical features. J. Cell Physiol. 143(1):118–128.
Mitchell, J.S., et al. (1965). Clinical trial of radiosensitizers, including Synkavit and oxygen inhaled at atmospheric pressure. Acta Radiol. Ther. Phys. Biol. 3(5):329–341.
Akman, S.A., et al. (1984). Differential pulse polarographic determination of plasma menadione. Anal. Biochem. 141:488–493.
Akman, S.A., et al. (1988). Phase I trial of menadiol sodium diphosphate in advanced cancer. Proc. Am. Soc. Clin. Oncol. 7:76.
Noto, V., et al. (1989). Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action. Cancer 63(5):901–906.
Venugopal, J., et al. (1996). Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines. Life Sci. 59:1389–1400.
Venugopal, M., et al. (1996). Synergistic antitumor activity of vitamins C and K3 against human prostate carcinoma cell lines. Cell Biol. Int. 20:787–797.
Taper, H.S., et al. (1987). Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment. Int. J. Cancer 40:575–579.
Taper, H.S., et al. (1996). Potentiation of radiotherapy by nontoxic pretreatment with combined vitamins C and K3 in mice bearing solid transplantable tumor. Anticancer Res. 16:499–504.
Taper, H.S., et al. (2001). In vivo reactivation of DNAses in implanted human prostate tumors following administration of a vitamin C: K3 combination. J. Histochem. Cytochem. 49:109–120.
Jamison, J.M., et al. (2001). Evaluation of the in vitro and in vivo antitumor activities of vitamin C and K-3 combinations against human prostate cancer. J. Nutr. 131:158S-160S.
Gilloteaux, J., et al. (1998). Cancer cell necrosis by autoschizis: synergism of antitumor activity on vitamin C-vitamin K3 on human bladder carcinoma T24 cells. Scanning 20:564.
Gilloteaux, J., et al. (2001). Ultrastructural aspects of autoschizis: a new cancer cell death induced by the synergistic action of ascrobate/menadione on human bladder carcinoma cells. Ultrastruct. Pathol. 25:183–192.
Nassiri, M.R., et al. (1999). Flow cytometric evaluation of two human carcinoma cell lines confirms cell autoschizis potentiated by the synergism of vitamins C and K3 tumor cell growth in vitro. J. Scan. Microsc. 21:108–109.
Sung, C.-F., et al. (2002). Serum total homocysteine increases with the rapid proliferation of tumor cells and decline upon cell death: a potential new tumor marker. Clin. Chim. Acta 321:55–62.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lasalvia-Prisco, E., Cucchi, S., Vázquez, J. et al. Serum markers variation consistent with autoschizis induced by ascrobic acid-menadione in patients with prostate cancer. Med Oncol 20, 45–52 (2003). https://doi.org/10.1385/MO:20:1:45
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MO:20:1:45